Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density
- PMID: 15788684
- DOI: 10.1158/1078-0432.CCR-04-2263
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density
Abstract
Purpose: Recent studies have revealed that fucose removal from the oligosaccharides of human IgG1 antibodies results in a significant enhancement of antibody-dependent cellular cytotoxicity (ADCC) via improved IgG1 binding to FcgammaRIIIa. In this report, we investigated the relationship between enhanced ADCC and antigen density on target cells using IgG1 antibodies with reduced fucose.
Experimental design: Using EL4 cell-derived transfectants with differential expression levels of exogenous human CC chemokine receptor 4 or human CD20 as target cells, ADCC of fucose variants of chimeric IgG1 antibodies specific for these antigens were measured. We further investigated IgG1 binding to natural killer (NK) cells and NK cell activation during ADCC induction to elucidate the mechanism by which low-fucose IgG1 induces ADCC upon target cells with low antigen expression.
Results: Low-fucose IgG1s showed potent ADCC at low antigen densities at which their corresponding high-fucose counterparts could not induce measurable ADCC. The quantitative analysis revealed that fucose depletion could reduce the antigen amount on target cells required for constant degrees of ADCC induction by 10-fold for CC chemokine receptor 4 and 3-fold for CD20. IgG1 binding to NK cells was increased by ligating IgG1 with clustered antigen, especially for low-fucose IgG1. Up-regulation of an activation marker, CD69, on NK cells, particularly the CD56(dim) subset, in the presence of both the antibody and target cells was much greater for the low-fucose antibodies.
Conclusions: Our data showed that fucose removal from IgG1 could reduce the antigen amount required for ADCC induction via efficient recruitment and activation of NK cells.
Similar articles
-
Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6248-55. doi: 10.1158/1078-0432.CCR-04-0850. Clin Cancer Res. 2004. PMID: 15448014
-
Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.Clin Cancer Res. 2006 May 1;12(9):2879-87. doi: 10.1158/1078-0432.CCR-05-2619. Clin Cancer Res. 2006. PMID: 16675584
-
lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.Clin Cancer Res. 2008 Jul 15;14(14):4650-7. doi: 10.1158/1078-0432.CCR-07-4405. Clin Cancer Res. 2008. PMID: 18628480
-
Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.Anticancer Res. 2005 Nov-Dec;25(6A):3725-32. Anticancer Res. 2005. PMID: 16302732 Review.
-
[Potelligent antibodies as next generation therapeutic antibodies].Yakugaku Zasshi. 2009 Jan;129(1):3-9. doi: 10.1248/yakushi.129.3. Yakugaku Zasshi. 2009. PMID: 19122430 Review. Japanese.
Cited by
-
Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies.Blood Adv. 2023 Mar 28;7(6):918-932. doi: 10.1182/bloodadvances.2022008560. Blood Adv. 2023. PMID: 36469551 Free PMC article.
-
Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview.Proc Jpn Acad Ser B Phys Biol Sci. 2023;99(7):213-226. doi: 10.2183/pjab.99.014. Proc Jpn Acad Ser B Phys Biol Sci. 2023. PMID: 37518010 Free PMC article. Review.
-
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies.Front Immunol. 2022 Jun 30;13:929895. doi: 10.3389/fimmu.2022.929895. eCollection 2022. Front Immunol. 2022. PMID: 35844552 Free PMC article. Review.
-
Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro.PLoS One. 2015 Dec 29;10(12):e0145633. doi: 10.1371/journal.pone.0145633. eCollection 2015. PLoS One. 2015. PMID: 26713448 Free PMC article.
-
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity.Cancer Sci. 2009 Dec;100(12):2411-8. doi: 10.1111/j.1349-7006.2009.01327.x. Epub 2009 Aug 25. Cancer Sci. 2009. PMID: 19758394 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials